Quality-adjusted survival (Q-TWiST) analysis of EORTC trial 30853: comparing goserelin acetate and flutamide with bilateral orchiectomy in patients with metastatic prostate cancer. European Organization for Research and Treatment of Cancer. (Q53558519)

From Wikidata

Jump to navigation Jump to search

scientific article published in February 1999

Language	Label	Description	Also known as
English	Quality-adjusted survival (Q-TWiST) analysis of EORTC trial 30853: comparing goserelin acetate and flutamide with bilateral orchiectomy in patients with metastatic prostate cancer. European Organization for Research and Treatment of Cancer.	scientific article published in February 1999

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9973095%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Quality-adjusted survival (Q-TWiST) analysis of EORTC trial 30853: comparing goserelin acetate and flutamide with bilateral orchiectomy in patients with metastatic prostate cancer. European Organization for Research and Treatment of Cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9973095%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Ingvar Rosendahl

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9973095%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9973095%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

author name string

G M Kiebert

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9973095%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

B F Cole

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9973095%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

J C Weeks

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9973095%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

L J Denis

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9973095%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

R R Hall

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9973095%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

publication date

1 February 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9973095%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9973095%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

38

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9973095%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9973095%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

100-109

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9973095%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Estimating the cost effectiveness of total androgen blockade with flutamide in M1 prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990201%2938%3A2%3C100%3A%3AAID-PROS3%3E3.0.CO%3B2-X

21 January 2018

Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III EORTC trial (30853). EORTC GU Group and EORTC Data Center

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990201%2938%3A2%3C100%3A%3AAID-PROS3%3E3.0.CO%3B2-X

21 January 2018

Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990201%2938%3A2%3C100%3A%3AAID-PROS3%3E3.0.CO%3B2-X

21 January 2018

A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990201%2938%3A2%3C100%3A%3AAID-PROS3%3E3.0.CO%3B2-X

21 January 2018

Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990201%2938%3A2%3C100%3A%3AAID-PROS3%3E3.0.CO%3B2-X

21 January 2018

Quality-of-life-adjusted survival analysis of interferon alfa-2b adjuvant treatment of high-risk resected cutaneous melanoma: an Eastern Cooperative Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990201%2938%3A2%3C100%3A%3AAID-PROS3%3E3.0.CO%3B2-X

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990201%2938%3A2%3C100%3A%3AAID-PROS3%3E3.0.CO%3B2-X

21 January 2018

Health-related quality of life among patients with metastatic prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990201%2938%3A2%3C100%3A%3AAID-PROS3%3E3.0.CO%3B2-X

21 January 2018

Measuring the quality of life of cancer patients: a concise QL-index for use by physicians.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990201%2938%3A2%3C100%3A%3AAID-PROS3%3E3.0.CO%3B2-X

21 January 2018

Quality adjusted survival analysis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990201%2938%3A2%3C100%3A%3AAID-PROS3%3E3.0.CO%3B2-X

21 January 2018

Prostate cancer--what should be studied?

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990201%2938%3A2%3C100%3A%3AAID-PROS3%3E3.0.CO%3B2-X

21 January 2018

A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990201%2938%3A2%3C100%3A%3AAID-PROS3%3E3.0.CO%3B2-X

21 January 2018

Identifiers

10.1002/(SICI)1097-0045(19990201)38:2<100::AID-PROS3>3.0.CO;2-X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9973095%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9973095%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53558519&oldid=1360861492"